S&P 500

Viatris (VTRS) — 10-Year DCF Projection Model

Free stock research tool. Build a 10-year revenue, earnings (EPS), and free cash flow forecast for Viatris (VTRS) stock, a company in the Health Care (Pharmaceuticals) sector. Pulls audited SEC EDGAR XBRL financials, triangulates Wall Street analyst consensus across Yahoo Finance, NASDAQ, and StockAnalysis, and overlays AI-clustered news + social event probabilities directly onto projected EPS. For equity research — not personal budgeting or accounting.

Build VTRS projection model →Browse all stocks

Viatris at a glance

Ticker
VTRS
Company
Viatris
Sector
Health Care
Sub-industry
Pharmaceuticals
Headquarters
Pittsburgh, Pennsylvania
Founded
1961
Added to S&P 500
2004-04-23
Index membership
S&P 500

What you'll see in your VTRS model

  • 10 years of audited historical financials for Viatris, sourced directly from the SEC's EDGAR XBRL filings (10-K and 10-Q).
  • Triangulated Wall Street consensus for VTRS's forward revenue, EBITDA, and EPS across Yahoo Finance, NASDAQ, and StockAnalysis with cross-source dispersion (σ).
  • AI Event Factors: top-10 news/social themes for VTRS with probability sliders and live EPS impact.
  • Sensitivity tables and Excel export for every assumption.

About Viatris

Viatris (NYSE/NASDAQ: VTRS) was founded in 1961 and is headquartered in Pittsburgh, Pennsylvania. The company operates in the Health Care sector (Pharmaceuticals sub-industry) and is a constituent of the S&P 500. Our projection model builds a clean discounted-cash-flow view of Viatris in roughly five seconds and lets you adjust every assumption to test your own thesis.